![]() |
市場調查報告書
商品編碼
1725110
2032 年靜脈穿刺程序市場預測:按產品類型、靜脈類型、技術、應用、最終用戶和地區進行的全球分析Venipuncture Procedure Market Forecasts to 2032 - Global Analysis By Product Type (Needles, Syringes, Blood Collection Tubes, and Other Product Types), Vein Type, Technique, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球靜脈穿刺手術市場預計在 2025 年達到 14.2 億美元,預計到 2032 年將達到 24.3 億美元,預測期內的複合年成長率為 8.0%。
靜脈穿刺是一種將針頭插入靜脈以抽血或注射藥物或液體的醫療程序。它通常在手臂上進行,對於診斷測試、輸血和靜脈治療至關重要。此過程需要技巧來盡量減少不適並減少併發症。它由經過培訓的醫療保健專業人員(例如採血員、護士和醫療技術人員)在醫院、診所和實驗室定期進行。
根據美國疾病管制與預防中心2021年發布的數據,每年約有80.5萬人接受此檢測。美國每年約有 805,000 人心臟病發作,20 歲以上的成年人中約有二十分之一患有冠狀動脈疾病 (CAD)。
慢性病增多
糖尿病、癌症和心血管疾病等慢性疾病的盛行率不斷上升,推動了靜脈穿刺手術的需求。慢性疾病通常需要定期驗血以進行診斷、治療監測和管理,從而推動市場發展。醫療保健基礎設施和診斷工具的進步極大地改善了靜脈穿刺服務的可近性。政府促進早期診斷和預防性醫療保健的舉措進一步推動了這種日益成長的需求。此外,人口老化使得人們更容易患上慢性疾病,這也推動了靜脈穿刺服務的需求。
缺乏訓練有素的採血員
靜脈穿刺手術市場因熟練採血師嚴重短缺而受到限制。經過適當培訓的人員對於確保安全有效地採集血液以及最大限度地減少錯誤和患者不適的風險至關重要。許多地區缺乏適當的培訓計劃和資格,加劇了這個問題。此外,醫療保健行業的高員工離職率也導致經驗豐富的專業人員短缺。這項挑戰在衛生資源有限的農村和低度開發地區尤為明顯。
門診和居家醫療服務的成長
人們對門診和家庭醫療保健服務的日益成長的偏好為靜脈穿刺手術市場創造了巨大的機會。這些環境提供了便利性、節省了成本並提高了患者的舒適度,從而推動了它們的普及。就地檢驗和可攜式診斷設備的擴展進一步推動了這一趨勢。技術的進步使得在傳統臨床環境之外進行精確的靜脈穿刺手術成為可能。此外,對個人化醫療保健解決方案的需求不斷成長與這些服務的成長相吻合。
對非侵入性診斷的偏好日益成長
非侵入性診斷技術的日益普及對靜脈穿刺手術市場構成了威脅。與抽血相比,唾液、尿液檢查和呼吸檢測等方法侵入性較小,對患者也較友善。這些技巧對於在靜脈穿刺過程中感到焦慮或不適的患者特別有吸引力。此外,穿戴式健康監測設備的進步也減少了頻繁抽血的需求。隨著這些替代療法變得更加容易取得和可靠,它們可能會取代傳統的靜脈穿刺。
COVID-19的影響
COVID-19 疫情對靜脈穿刺手術市場產生了重大影響。最初,醫療系統的封鎖和中斷導致非緊急血液檢測和診斷的減少。然而,這場大流行也凸顯了及時診斷服務的重要性,這有助於最終的康復。疫情過後,人們對定期健康檢查和診斷的認知提高預計將推動成長。這場大流行凸顯了靜脈穿刺在醫療保健中的重要作用,並強化了其長期重要性。
預計頭部靜脈段在預測期內將是最大的。
由於頭靜脈採血具有良好的可及性和易用性,預計在預測期內將佔據最大的市場佔有率。此靜脈通常用於靜脈穿刺手術,尤其是在門診病人和急診環境。其突出的位置有助於最大限度地減少併發症並提高患者的舒適度,因此越來越受到醫療保健專業人士的偏好。此外,對慢性病常規診斷和監測的需求不斷增加,進一步推動了頭靜脈的利用。
預計在預測期內,醫院部門的複合年成長率最高。
由於醫院部門是靜脈穿刺服務的主要提供者,預計在預測期內將出現最高的成長率。醫院正在推動市場佔有率,因為它們要處理大量需要採血的診斷和治療程序。醫院實驗室先進技術與自動化的結合提高了靜脈穿刺過程的準確性和效率。此外,醫院處理複雜病例和緊急情況的能力使其成為市場中的主要企業。
在預測期內,亞太地區預計將佔據最大的市場佔有率,這得益於其快速擴張的醫療保健基礎設施。該地區人口眾多,慢性病盛行率不斷上升,增加了靜脈穿刺的需求。政府推動疾病早期發現和預防性醫療保健的舉措將進一步推動市場成長。此外,可支配收入的增加和醫療保健服務的改善也促進了診斷活動的增加。
預計北美地區在預測期內將呈現最高的複合年成長率。這是得益於先進的醫療保健系統和大量的診斷測試。該地區受益於大規模的醫療保健投資和對研發的高度重視。診斷技術和自動化方面的創新支持了靜脈穿刺的高效進行。此外,人們對預防性醫療保健和定期檢查的認知不斷提高,也推動市場的發展。
According to Stratistics MRC, the Global Venipuncture Procedure Market is accounted for $1.42 billion in 2025 and is expected to reach $2.43 billion by 2032 growing at a CAGR of 8.0% during the forecast period. Venipuncture is a medical procedure that involves puncturing a vein with a needle to withdraw blood or administer medications and fluids. Commonly performed on the arm, it is essential for diagnostic testing, transfusions, and intravenous therapy. The procedure requires skill to ensure minimal discomfort and reduce complications. It is routinely conducted in hospitals, clinics, and laboratories by trained healthcare professionals such as phlebotomists, nurses, or medical technicians.
According to the Centers for Disease Control and Prevention data published in 2021. Every year, about 805,000 people in the U.S. suffered with heart attack and about 1 in 20 adults aged 20 and older have coronary artery disease (CAD).
Rising prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is driving the demand for venipuncture procedures. Chronic diseases often require routine blood tests for diagnosis, treatment monitoring, and management, thus boosting the market. With advancements in healthcare infrastructure and diagnostic tools, access to venipuncture services has improved significantly. This growing demand is further supported by government initiatives promoting early diagnosis and preventive healthcare. Additionally, an aging population prone to chronic conditions adds to the necessity of venipuncture services.
Shortage of trained phlebotomists
The venipuncture procedure market is restrained by a notable shortage of skilled phlebotomists. Properly trained personnel are crucial to ensure safe and effective blood collection, minimizing the risk of errors and patient discomfort. The lack of adequate training programs and certifications in many regions exacerbates this issue. Moreover, high staff turnover in the healthcare sector contributes to the scarcity of experienced professionals. This challenge is particularly pronounced in rural and underdeveloped areas, where healthcare resources are limited.
Growth in outpatient and home care services
The increasing preference for outpatient care and home healthcare services presents a significant opportunity for the venipuncture procedure market. These settings offer convenience, reduced costs, and enhanced patient comfort, driving their adoption. The expansion of point-of-care testing and portable diagnostic devices further supports this trend. Advances in technology enable precise venipuncture procedures outside traditional clinical environments. Moreover, the rising demand for personalized healthcare solutions aligns with the growth of these services.
Rising preference for non-invasive diagnostic alternatives
The growing popularity of non-invasive diagnostic techniques poses a threat to the venipuncture procedure market. Methods such as saliva, urine, and breath tests offer a less invasive and more patient-friendly alternative to blood collection. These technologies are particularly appealing to patients who experience anxiety or discomfort during venipuncture. Additionally, advancements in wearable health monitoring devices are reducing the need for frequent blood draws. As these alternatives become more accessible and reliable, they may displace traditional venipuncture procedures.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the venipuncture procedure market. During the initial phases, lockdowns and healthcare system disruptions led to a decline in non-urgent blood tests and diagnostics. However, the pandemic also highlighted the importance of timely diagnostic services, leading to an eventual recovery. Post-pandemic, heightened awareness about regular health check-ups and diagnostics is expected to drive growth. The pandemic underscored the critical role of venipuncture in healthcare, reinforcing its importance in the long term.
The cephalic vein segment is expected to be the largest during the forecast period
The cephalic vein segment is expected to account for the largest market share during the forecast period, due to its accessibility and ease of use for blood collection. This vein is commonly chosen for venipuncture procedures, especially in outpatient and emergency settings. Its prominent location minimizes complications and enhances patient comfort, increasing its preference among healthcare professionals. Additionally, the growing demand for routine diagnostics and chronic disease monitoring further drives the utilization of cephalic vein.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their role as primary providers of venipuncture services. Hospitals handle a high volume of diagnostic and therapeutic procedures requiring blood collection, driving their market share. The integration of advanced technologies and automation in hospital labs enhances the accuracy and efficiency of venipuncture processes. Additionally, hospitals' ability to cater to complex cases and emergency situations positions them as key players in the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare infrastructure. The region's large population and increasing prevalence of chronic diseases drive the demand for venipuncture procedures. Government initiatives promoting early disease detection and preventive care further enhance market growth. Additionally, rising disposable incomes and improved access to healthcare services contribute to increased diagnostic activities.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare systems and high diagnostic test volumes. The region benefits from extensive healthcare investments and a strong focus on research and development. Innovations in diagnostic technologies and automation support the efficient conduct of venipuncture procedures. Moreover, increasing awareness about preventive healthcare and routine check-ups drives the market.
Key players in the market
Some of the key players profiled in the Venipuncture Procedure Market include Becton, Dickinson and Company (BD), Terumo Corporation, Quest Diagnostics, Greiner Bio-One International, Fresenius Kabi AG, AccuVein Inc., Smiths Medical, B. Braun Medical, Christie Medical Holdings, Inc., TransLite, LLC, Sharn Anesthesia, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific, BioReference Health, LLC, and UNILABS.
In April 2025, BD announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix(TM) ST Umbilical Hernia Patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.
In March 2025, Terumo Vietnam Medical Equipment and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam. The initiative aims to support healthcare professionals in updating their knowledge and skills in interventional cardiology.